| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrine Care |
Center for Research in Womens Health, Sunnybrook and Womens College Health Sciences Center (T.P., S.B., S.A.N.), Toronto, Ontario, Canada M5G 1N8; Unit of Genetic Epidemiology, International Agency for Research on Cancer (F.D.V., H.R., D.E.G.), 69008 Lyon, France; Division of Medical Genetics, Department of Medicine, Montréal General Hospital and Cancer Prevention Research Unit, Sir Mortimer B. Davis-Jewish General Hospital, McGill University (P.O.C., K.S., T.K.), Montréal, Québec, Canada H3G 1A4; Department of Radiation Oncology, Princess Margaret Hospital, University Health Network (R.T., J.B.), Toronto, Ontario, Canada M5G 2M9; and Program in Cancer Genetics, Departments of Oncology and Human Genetics (W.D.F.), McGill University, Montréal, Québec, Canada H2W 1S6
Address all correspondence and requests for reprints to: W. D. Foulkes, M.B., Ph.D., Division of Medical Genetics, Montréal General Hospital/Room L10-120, 1650 Cedar Avenue, Montréal, Québec, Canada H3G 1A4. E-mail: william.foulkes{at}mcgill.ca
Abstract
The genetic basis for nonmedullary forms of thyroid cancer (NMTC) is less well established than that of medullary thyroid cancer. However, epidemiological and family studies suggest that a proportion of NMTC may be due to inherited predisposition. To estimate the familial risk of thyroid cancer, we conducted a hospital-based case-control study at the Princess Margaret Hospital in Toronto, Ontario, Canada, and at 2 university hospitals in Montréal, Québec, Canada. We obtained pedigrees from 339 unselected patients diagnosed with NMTC and from 319 unaffected ethnically matched controls. Family histories of cancer were obtained from the cases and controls for 3292 first degree relatives of cases and controls. Seventeen cases (5.0%) and 2 controls (0.6%) reported at least one first degree relative with thyroid cancer.
In relatives of patients with thyroid cancer, the incidence of any type of cancer (including NMTC) was 38% higher than in relatives of controls (incidence rate ratio, 1.4; 95% confidence interval, 1.11.7). The relative risk for thyroid cancer was 10-fold higher in relatives of cancer patients than in controls (incidence rate ratio, 10.3; 95% confidence interval, 2.247.6).
Our findings suggest that hereditary or other familial factors are important in a small proportion of NMTC. Molecular studies are needed to determine the genetic basis of cancer susceptibility in these families.
This article has been cited by other articles:
![]() |
M Capezzone, S Marchisotta, S Cantara, G Busonero, L Brilli, K Pazaitou-Panayiotou, A F Carli, G Caruso, P Toti, S Capitani, et al. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity Endocr. Relat. Cancer, December 1, 2008; 15(4): 1075 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hemminki, C. Eng, and B. Chen Familial Risks for Nonmedullary Thyroid Cancer J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5747 - 5753. [Abstract] [Full Text] [PDF] |
||||
![]() |
J D McKay, D Thompson, F Lesueur, K Stankov, A Pastore, C Watfah, S Strolz, G Riccabona, R Moncayo, G Romeo, et al. Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer J. Med. Genet., June 1, 2004; 41(6): 407 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Malchoff and D. M. Malchoff The Genetics of Hereditary Nonmedullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2455 - 2459. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |